** Cochlear's COH.AX shares advance as much as 6.7% to
A$311.29, set for best day since Aug. 15, 2023 - if gains hold
** The medical device firm upgrades its FY24 underlying net
profit to be between A$385 million ($251.14 million) and A$400
million, a 26%-31% increase from FY23 and 8% above previous
forecast mid-point of A$355 mln to A$375 mln
** Forecast of A$385 mln - A$400 mln is 7% above Visible
Alpha consensus of A$367 mln, according to Citi
** Co records H1 sales revenue of A$1.11 bln, with an
underlying net profit of A$192 mln
** Shares have fallen 2.3% this year, as of last close
($1 = 1.5330 Australian dollars)
(Reporting by Archishma Iyer in Bengaluru)
((Archishma.Iyer@thomsonreuters.com;))